Simmons Bank Bristol Myers Squibb CO Transaction History

Simmons Bank

$1.37 Billion
Q3 2024

A detailed history of Simmons Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Simmons Bank holds 39,476 shares of BMY stock, worth $2.28 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

39,476

Previous 44,267 10.82%

Holding current value

$2.28 Million

Previous $1.84 Million 11.1%

% of portfolio

0.15%

Previous 0.14%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$39.66 - $51.75 $190,011 - $247,934	-4,791 Reduced 10.82%	39,476 $2.04 Million
Q2 2024 Jul 26, 2024	SELL	$40.25 - $52.99 $49,306 - $64,912	-1,225 Reduced 2.69%	44,267 $1.84 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $10,267 - $11,641	-214 Reduced 0.47%	45,492 $2.47 Million
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $215,978 - $257,721	-4,455 Reduced 8.88%	45,706 $2.35 Million
Q3 2023 Oct 26, 2023	SELL	$57.89 - $64.73 $96,097 - $107,451	-1,660 Reduced 3.2%	50,161 $2.91 Million
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $73,393 - $81,492	-1,152 Reduced 2.17%	51,821 $3.31 Million
Q1 2023 Apr 28, 2023	SELL	$65.71 - $74.53 $131,288 - $148,910	-1,998 Reduced 3.63%	52,973 $3.67 Million
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $119,566 - $141,583	-1,746 Reduced 3.08%	54,971 $3.95 Million
Q3 2022 Oct 27, 2022	SELL	$0.13 - $76.84 $363 - $215,075	-2,799 Reduced 4.7%	56,717 $4.03 Million
Q2 2022 Jul 29, 2022	SELL	$72.62 - $79.98 $98,327 - $108,292	-1,354 Reduced 2.22%	59,516 $4.58 Million
Q1 2022 Apr 21, 2022	SELL	$61.48 - $73.72 $580,186 - $695,695	-9,437 Reduced 13.42%	60,870 $4.45 Million
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $223,208 - $260,208	-4,162 Reduced 5.59%	70,307 $4.38 Million
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $68,992 - $80,815	-1,166 Reduced 1.54%	74,469 $4.41 Million
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $326,327 - $355,370	-5,271 Reduced 6.51%	75,635 $5.05 Million
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $294,267 - $330,963	-4,959 Reduced 5.78%	80,906 $5.11 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $250,764 - $284,162	-4,343 Reduced 4.81%	85,865 $5.33 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $95,104 - $105,387	-1,656 Reduced 1.8%	90,208 $5.44 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $6,413 - $7,498	-117 Reduced 0.13%	91,864 $5.4 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $223,787 - $325,214	4,823 Added 5.53%	91,981 $5.13 Million
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $737,018 - $961,373	14,977 Added 20.75%	87,158 $5.6 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $1.93 Million - $2.29 Million	45,215 Added 167.67%	72,181 $3.66 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $67,733 - $74,898	-1,518 Reduced 5.33%	26,966 $1.22 Million
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $83,832 - $99,960	-1,858 Reduced 6.12%	28,484 $1.36 Million
Q4 2018 Jan 24, 2019	SELL	$48.76 - $63.23 $44,371 - $57,539	-910 Reduced 2.91%	30,342 $1.58 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $6,567 - $7,407	-119 Reduced 0.38%	31,252 $1.94 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $24,102 - $30,041	477 Added 1.54%	31,371 $1.74 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $386,903 - $445,403	6,457 Added 26.42%	30,894 $3.51 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $74,025 - $80,707	-1,235 Reduced 4.81%	24,437 $1.5 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $129,790 - $149,789	2,350 Added 10.08%	25,672 $1.64 Million
Q2 2017 Aug 15, 2017	BUY	N/A	23,322	23,322 $1.3 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simmons Bank, based on Form 13F filings with the SEC.

News

Stay updated on Simmons Bank with notifications on news.

Account